Crown (CCK) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
The 2025 Annual Meeting is scheduled for May 1, 2025, with shareholders voting on four key proposals, including director elections, auditor ratification, executive compensation, and a shareholder proposal on political spending transparency.
Only shareholders of record as of March 11, 2025, are eligible to vote, with multiple voting methods available until April 30, 2025.
The Board recommends voting for all director nominees, for auditor ratification and executive compensation, and against the shareholder proposal on political spending.
Voting matters and shareholder proposals
Four proposals: election of nine directors, ratification of PricewaterhouseCoopers LLP as independent auditors, advisory vote on executive compensation, and a shareholder proposal on political spending transparency.
The Board recommends voting for the first three proposals and against the shareholder proposal.
The shareholder proposal on political spending transparency received 48% support in 2024 but is opposed by the Board, citing adequate existing controls and disclosure.
Board of directors and corporate governance
Nine director nominees, eight of whom are independent; six joined in the last six years as part of a board refreshment process.
The Board is diverse, with three female directors and one African American director.
Board committees (Audit, Compensation, Nominating and Corporate Governance) are composed solely of independent directors.
Annual election of all directors, mandatory retirement policy, proxy access, and no supermajority voting requirement for by-law amendments.
Shareholder right to call special meetings and prohibition on poison pills.
Latest events from Crown
- Board recommends director elections, auditor ratification, pay approval, and opposes written consent.CCK
Proxy filing23 Mar 2026 - Record EBITDA, strong cash flow, and improved leverage drive positive 2026 outlook.CCK
Q4 20255 Feb 2026 - Strong global beverage can growth, higher earnings, and a $2B buyback program announced.CCK
Q2 20243 Feb 2026 - Strong beverage can growth and higher income offset by pension settlement charges.CCK
Q3 202419 Jan 2026 - Record EBITDA, strong cash flow, and reduced leverage highlight a positive 2025 outlook.CCK
Q4 20248 Jan 2026 - Q1 net income up to $193M, adjusted EPS up 64%, and guidance raised on strong can demand.CCK
Q1 20256 Jan 2026 - Q2 adjusted EPS up 19%, sales and cash flow strong, and guidance raised for the year.CCK
Q2 20254 Nov 2025 - Q3 2025 delivered higher sales, strong European growth, and raised guidance with robust shareholder returns.CCK
Q3 202530 Oct 2025